Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

CLINICAL MEASUREMENT - ANNOTATIONS

The Clinical Measurement Ontology (CMO), Measurement Methods Ontology (MMO), and Experimental Condition Ontology (XCO) are currently being developed at the Rat Genome Database. For more information about these vocabularies please see Shimoyama et al. Three ontologies to define phenotype measurement data. Front Genet. 2012;3:87. Epub 2012 May 28 or contact us (http://rgd.mcw.edu/contact/index.shtml).

Term:liver non-tumorous lesion incidence/prevalence measurement
go back to main search page
Accession:CMO:0002254 term browser browse the term
Definition:A measurement in which the number of individuals in a study population that display one or more non-tumorous lesion(s) of the liver at a point in time or develop such lesions within a determined period of time are compared to the total number of individuals in the study population. Often expressed as a percentage but could be expressed as a ratio.



show annotations for term's descendants           Sort by:
 

Term paths to the root
Path 1
Term Annotations click to browse term
  clinical measurement 2369
    disease population measurement 57
      disease incidence/prevalence measurement 57
        organ non-tumorous lesion incidence/prevalence measurement 4
          liver non-tumorous lesion incidence/prevalence measurement 0
            liver edema incidence/prevalence measurement + 0
            liver hyperemia incidence/prevalence measurement + 0
            liver parenchymal degeneration incidence/prevalence measurement + 0
Path 2
Term Annotations click to browse term
  clinical measurement 2369
    organ measurement 485
      organ lesion measurement 140
        organ non-tumorous lesion measurement 28
          organ non-tumorous lesion incidence/prevalence measurement 4
            liver non-tumorous lesion incidence/prevalence measurement 0
              liver edema incidence/prevalence measurement + 0
              liver hyperemia incidence/prevalence measurement + 0
              liver parenchymal degeneration incidence/prevalence measurement + 0
paths to the root